MIRATI THERAPEUTICS INC shareholders Q2 2023

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.

MIRATI THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$113,30282.86%
ORACLE INVESTMENT MANAGEMENT INC 152,600$5,513,4384.06%
Paradigm Biocapital Advisors LP 1,443,762$52,163,1214.03%
Octagon Capital Advisors LP 750,000$27,097,5003.77%
Boxer Capital, LLC 2,000,000$72,2603.35%
RTW INVESTMENTS, LP 4,472,985$161,608,9483.08%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 260,000$9,393,8002.86%
Avoro Capital Advisors LLC 5,555,555$200,722,2022.72%
Ghost Tree Capital, LLC 200,000$7,226,0002.38%
Artal Group S.A. 2,055,181$74,2542.30%
Camber Capital Management LP 1,800,000$65,0342.12%
ARMISTICE CAPITAL, LLC 3,978,000$143,725,1402.08%
5AM Venture Management, LLC 192,500$6,955,0251.73%
SILVERARC CAPITAL MANAGEMENT, LLC 150,000$5,419,5001.68%
SILVERARC CAPITAL MANAGEMENT, LLC 91,213$3,295,5261.02%
Rock Springs Capital Management LP 1,121,647$40,525,1060.96%
DAFNA Capital Management LLC 94,700$3,421,5110.94%
SECTORAL ASSET MANAGEMENT INC 148,553$5,367,2200.90%
Perceptive Advisors 719,103$25,981,1910.75%
Orbimed Advisors 913,650$33,010,1750.60%
External links

This page lists MIRATI THERAPEUTICS INC's shareholders in Q2 2023. To view MIRATI THERAPEUTICS INC's shareholder history, click here.